Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with <i>RAS</i>/<i>BRAF</i> Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University), Ping Lan(Sun Yat-sen University), Zehua Wu(Shanghai Jiao Tong University), Rongbo Lin(Fujian Provincial Cancer Hospital), Guangjian Liu(Sun Yat-sen University), Meng Qiu(Northeast Normal University), Jiayu Ling(Sun Yat-sen University), Yue Cai(Sun Yat-sen University), Meijin Huang(Sun Yat-sen University), Huaiming Wang(Sun Yat-sen University), Tenghui Ma(Sun Yat-sen University), Liang Kang(Sun Yat-sen University), Jianwei Zhang(Capital Medical University), Ming Liu(Guizhou Center for Disease Control and Prevention), Kun Wang(Chinese Academy of Sciences), Wei Wang(Central South University), Haibo Zhang(Guangzhou University of Chinese Medicine), Li Ling(Xinjiang Academy of Forestry), Hui Wang(People’s Hospital of Rizhao), Yonghua Cai(Sun Yat-sen University), Xiaojian Wu(Guangxi Academy of Agricultural Science), Jiaming Zhou(Sun Yat-sen University), Shuangling Luo(Sun Yat-sen University), Yunle Wan(Sun Yat-sen University), Yan Huang(Xinxiang Medical University), Zhiyang Zhou(Shanghai Jiao Tong University), Fangqian Li(Central South University)
Cited by 50
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence
|Nature Medicine|2019|710
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657